India’s Cipla plans $512 million takeover of South Africa’s Cipla Medpro

Hamied, chairman and MD of Indian generic drugmaker Cipla, poses for picture in front of cabinet containing company's products before an interview in Mumbai* Raises per-share price to 10 rand from 8.55 rand * Plans to delist Cipla Medpro when sale complete MUMBAI (Reuters) – Indian drugmaker Cipla Ltd on Thursday sweetened its offer by 17 percent to take over South Africa's third-largest drugmaker, Cipla Medpro South Africa Ltd, ending the uncertainty of an earlier offer that had been put on hold by the Indian company. Cipla, India's fifth-largest drugmaker by sales, said it would spend about $512 million, or 10 rand a share, to acquire Cipla Medpro and then delist the South African drugmaker. …

Special program increases birth control use in at-risk teens

(Reuters) – Long after completing an 18-month program designed to teach them about contraception and healthy relationships, U.S. teens at high risk for pregnancy were still using contraceptives more often, among other safe sexual practices, a U.S. study said. The teen pregnancy rate in the United States is the highest in the developed world, researchers writing in JAMA Pediatrics said. According to the U.S. Centers for Disease Control and Prevention, in 2011 31 out of every 1,000 U.S. teenage girls between the ages of 15 and 19 gave birth to a baby. …

Arkansas House overrides veto of late-term abortion ban

LITTLE ROCK, Ark (Reuters) – The Republican-controlled Arkansas House of Representatives on Wednesday overrode a veto by Democratic Governor Mike Beebe of a bill to ban most late-term abortions in the state at 20 weeks into pregnancy. The House voted 53-28 to override the veto, and the Republican-dominated state Senate was expected to vote on Thursday to override the veto as well. If that happens, Arkansas would join seven other U.S. states that restrict or ban abortions after the 20-week mark. …

1 2 3 4 5 82